Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and dev ...

IVIg is administered in a standard dose of 2 g/kg divided over 3-5 days; however, despite this therapy, some patients ... treated with 2 g/kg of IVIg. Total IgG levels were determined in serum ...

responses to the tetanus vaccine was similar in both groups—39.1% of rituximab-treated patients had a 4-fold or greater increase in anti-tetanus immunoglobulin G titers from baseline compared ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

This article reviews IVIG therapy, its uses, how it works, and what to expect when receiving it. Immunoglobulins are also ...